Slovenia - English - HMA (Heads of Medicines Agencies)

merial animal health ltd - salmonella enteritidis inactivated 47 iu, salmonella typhimurium inactivated 116 iu - emulsion for injection - chicken layers, chicken other - salmonella vaccine

United Kingdom - English - HMA (Heads of Medicines Agencies)

merial animal health ltd - salmonella enteritidis inactivated 47 iu, salmonella typhimurium inactivated 116 iu - emulsion for injection - chicken layers, chicken other - salmonella vaccine

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

zoetis australia pty ltd - m. hyopneumoniae - inactivated whole cell culture; thiomersal - misc. vaccines or anti sera - m. hyopneumoniae - inactivated whole cell culture vaccine-general active 6000.0 ru/do; thiomersal mercury other 0.1 mg/ml - immunotherapy - pigs | boar | gilt | piglet | sow | swine - mycoplasma hyopneumoniae | vaccine | equine rotavirus | reduction of lung lesions | respiratory disease | swine enzootic pneumonia

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

intervet australia pty limited - fowl pox vaccine - misc. vaccines or anti sera - fowl pox vaccine vaccine-viral active 0.0 p - immunotherapy - poultry | turkeys | breeder | breeders | broiler | broiler breeder | chickens | chicks | chooks | day old chicks | hatchlings | - fowl pox

New Zealand - English - Medsafe (Medicines Safety Authority)

biocelect new zealand ltd - salmonella typhi strain ty21a berna 2000 million organisms (minimum); salmonella typhi vaccine live attenuated 2000 million organisms (ty21a strain; minimum); salmonella typhi strain ty21a berna 2000 million organisms - modified release capsule - 2000 million organisms - active: salmonella typhi strain ty21a berna 2000 million organisms (minimum) excipient: ascorbic acid casein hydrolysate dibutyl phthalate diethyl phthalate erythrosine ethylene glycol gelatin hypromellose phthalate lactose fast flo iron oxide red iron oxide yellow lactose monohydrate magnesium stearate sucrose titanium dioxide active: salmonella typhi vaccine live attenuated 2000 million organisms (ty21a strain; minimum) excipient: ascorbic acid casein hydrolysate dibutyl phthalate diethyl phthalate erythrosine ethylene glycol gelatin hypromellose phthalate iron oxide red iron oxide yellow lactose magnesium stearate sucrose titanium dioxide active: salmonella typhi strain ty21a berna 2000 million organisms excipient: ascorbic acid diethyl phthalate erythrosine ethylene glycol gelatin hypromellose phthalate iron oxide red iron oxide yellow lactose magnesium stearate methanol methylene chloride protein hydrolysate sucrose titanium dioxide - vivotif oral is indicated for active immunisation against typhoid in adults and children above 6 years of age. effectiveness in children below 6 years of age is not known at present.

Malta - English - Medicines Authority

smithkline beecham limited 980, great west road, brentford middlesex tw8 9gs, united kingdom - vi polysaccharide, of salmonella, typhi - solution for injection - vi polysaccharide of salmonella typhi 1 µg - vaccines

Ireland - English - HPRA (Health Products Regulatory Authority)

sanofi pasteur - salmonella typhi, vi antigen - solution for injection - 25/0.5 microgram(s) - typhoid, purified polysaccharide antigen

European Union - English - EMA (European Medicines Agency)

resilience biomanufacturing ireland limited - influenza vaccine (whole virion, inactivated) containing antigen of: a/vietnam/1203/2004 (h5n1) - influenza, human; immunization; disease outbreaks - vaccines - prophylaxis of influenza in an officially declared pandemic situation. pandemic influenza vaccine should be used in accordance with official guidance.

European Union - English - EMA (European Medicines Agency)

novartis vaccines and diagnostics s.r.l. - influenza virus surface antigens (haemagglutinin and neuraminidase) of strain a/viet nam/1194/2004 (h5n1) - influenza, human - vaccines - active immunisation against h5n1 subtype of influenza a virus.; this indication is based on immunogenicity data from healthy subjects from the age of 18 years onwards following administration of two doses of the vaccine containing a/vietnam/1194/2004 (h5n1)-like strain.; prepandemic influenza vaccine (h5n1) novartis vaccines and diagnostic should be used in accordance with official recommendations.

Australia - English - Department of Health (Therapeutic Goods Administration)

biocelect pty ltd - salmonella typhi -